The Prolidase Activity, Oxidative Stress, and Nitric Oxide Levels of Bladder Tissues with or Without Tumor in Patients with Bladder Cancer

dc.contributor.authorGecit, Ilhan
dc.contributor.authorEryilmaz, Recep
dc.contributor.authorKavak, Servet
dc.contributor.authorMeral, Ismail
dc.contributor.authorDemir, Halit
dc.contributor.authorPirincci, Necip
dc.contributor.authorTaken, Kerem
dc.date.accessioned2026-08-12T17:33:22Z
dc.date.issued2017
dc.departmentFırat Üniversitesi
dc.description.abstractThis study was designed to evaluate the malondialdehyde (MDA), glutathione (GSH) and nitric oxide (NO) levels, and also prolidase, glutathione peroxidase (GSH-Px), superoxide dismutase (SOD) enzyme activities in malignant and benign cancers of bladder tissue. A total of 59 patients admitted to our clinic due to microscopic or macroscopic haematuria, were prospectively included in the study. Because of some reasons (no request to participate in the study, the inability to reach, other malignancies, alcohol consumption, metabolic disease), eight patients were excluded from study. Of the 51 patients, 25 were bladder tumor patients, and 26 were patients without cancers. The bladder tissue samples were obtained from all patients under anesthesia (spinal, epidural or general) for the measurement of MDA, GSH and NO levels, and prolidase, GSH-Px and SOD enzyme activities. Among the patients with bladder cancers, 7 patients were females and 18 patients were males, with an average age of 68.4 +/- 2.49. Among patients without tumors, 6 patients were females and 20 patients were males, with an average age of 58 +/- 2.05. In patients with bladder tumors, the oxidants (MDA, NO, prolidase) were higher, and the antioxidants (SOD, GSH, GSH-Px) were lower than those in patients without tumors. It was concluded that the oxygen free radicals play a role in the etiology of bladder cancers similar to many other tumors and inflammatory conditions. Therefore, we assume that antioxidants may provide benefits in the prevention and treatment of bladder cancer.
dc.identifier.doi10.1007/s00232-017-9971-0
dc.identifier.endpage459
dc.identifier.issn0022-2631
dc.identifier.issn1432-1424
dc.identifier.issue5
dc.identifier.orcid0000-0003-2044-9086
dc.identifier.pmid28815271
dc.identifier.scopus2-s2.0-85027501034
dc.identifier.scopusqualityQ2
dc.identifier.startpage455
dc.identifier.urihttps://doi.org/10.1007/s00232-017-9971-0
dc.identifier.urihttps://hdl.handle.net/11508/56988
dc.identifier.volume250
dc.identifier.wosWOS:000411904600005
dc.identifier.wosqualityQ2
dc.indekslendigikaynakWeb of Science
dc.indekslendigikaynakScopus
dc.indekslendigikaynakPubMed
dc.language.isoen
dc.publisherSpringer
dc.relation.ispartofJournal of Membrane Biology
dc.relation.publicationcategoryMakale - Uluslararası Hakemli Dergi - Kurum Öğretim Elemanı
dc.rightsinfo:eu-repo/semantics/closedAccess
dc.snmzKA_WoS_20260511
dc.subjectCancer
dc.subjectBladder
dc.subjectStatus antioxidants
dc.subjectSuperoxide dismutase
dc.subjectNitric oxide
dc.subjectOxidative stress
dc.titleThe Prolidase Activity, Oxidative Stress, and Nitric Oxide Levels of Bladder Tissues with or Without Tumor in Patients with Bladder Cancer
dc.typeArticle

Dosyalar